PURPOSE: The purpose of this paper is to describe patient perspectives on survivorship care 1 year after cancer diagnosis. METHODS: The study was conducted at an integrated healthcare delivery system in western Washington State. Participants were patients with breast, colorectal, and lung cancer who had enrolled in a randomized control trial (RCT) of oncology nurse navigation to improve early cancer care. Those alive and enrolled in the healthcare system 1 year after diagnosis were eligible for this analysis. Participants completed surveys by phone. Questions focused on receipt of treatment summaries and care plans; discussions with different providers; patient opinions on who does and should provide their care; and patient perspectives primary care providers' (PCP) knowledge and skills related to caring for cancer survivors RESULTS: Of the 251 participants in the RCT, 230 (91.6%) responded to the 12-month phone survey and were included in this analysis; most (n = 183, 79.6%) had breast cancer. The majority (84.8%) considered their cancer specialist (e.g., medical, radiation, surgical or gynecological oncologist) to be their main provider for cancer follow-up and most (69.4%) had discussed follow-up care with that provider. Approximately half of patients were uncertain how well their PCP communicated with the oncologist and how knowledgeable s/he was in caring for cancer survivors. CONCLUSIONS: One year after diagnosis, cancer survivors continue to view cancer specialists as their main providers and are uncertain about their PCP's skills and knowledge in managing their care. Our findings present an opportunity to help patients understand what their PCPs can and cannot provide in the way of cancer follow-up care. IMPLICATIONS FOR CANCER SURVIVORS: Additional research on care coordination and delivery is necessary to help cancer survivors manage their care between primary care and specialty providers.
RCT Entities:
PURPOSE: The purpose of this paper is to describe patient perspectives on survivorship care 1 year after cancer diagnosis. METHODS: The study was conducted at an integrated healthcare delivery system in western Washington State. Participants were patients with breast, colorectal, and lung cancer who had enrolled in a randomized control trial (RCT) of oncology nurse navigation to improve early cancer care. Those alive and enrolled in the healthcare system 1 year after diagnosis were eligible for this analysis. Participants completed surveys by phone. Questions focused on receipt of treatment summaries and care plans; discussions with different providers; patient opinions on who does and should provide their care; and patient perspectives primary care providers' (PCP) knowledge and skills related to caring for cancer survivors RESULTS: Of the 251 participants in the RCT, 230 (91.6%) responded to the 12-month phone survey and were included in this analysis; most (n = 183, 79.6%) had breast cancer. The majority (84.8%) considered their cancer specialist (e.g., medical, radiation, surgical or gynecological oncologist) to be their main provider for cancer follow-up and most (69.4%) had discussed follow-up care with that provider. Approximately half of patients were uncertain how well their PCP communicated with the oncologist and how knowledgeable s/he was in caring for cancer survivors. CONCLUSIONS: One year after diagnosis, cancer survivors continue to view cancer specialists as their main providers and are uncertain about their PCP's skills and knowledge in managing their care. Our findings present an opportunity to help patients understand what their PCPs can and cannot provide in the way of cancer follow-up care. IMPLICATIONS FOR CANCER SURVIVORS: Additional research on care coordination and delivery is necessary to help cancer survivors manage their care between primary care and specialty providers.
Authors: D Howell; T F Hack; T K Oliver; T Chulak; S Mayo; M Aubin; M Chasen; C C Earle; A J Friedman; E Green; G W Jones; J M Jones; M Parkinson; N Payeur; C M Sabiston; S Sinclair Journal: J Cancer Surviv Date: 2012-07-10 Impact factor: 4.442
Authors: Erin E Kent; Neeraj K Arora; Julia H Rowland; Keith M Bellizzi; Laura P Forsythe; Ann S Hamilton; Ingrid Oakley-Girvan; Ellen B Beckjord; Noreen M Aziz Journal: Patient Educ Couns Date: 2012-09-28
Authors: Larissa Nekhlyudov; Sarah M Greene; Jessica Chubak; Borsika Rabin; Leah Tuzzio; Sharon Rolnick; Terry S Field Journal: J Cancer Surviv Date: 2012-12-14 Impact factor: 4.442
Authors: Arnold L Potosky; Paul K J Han; Julia Rowland; Carrie N Klabunde; Tenbroeck Smith; Noreen Aziz; Craig Earle; John Z Ayanian; Patricia A Ganz; Michael Stefanek Journal: J Gen Intern Med Date: 2011-07-22 Impact factor: 5.128
Authors: Ted A Skolarus; Margaret Holmes-Rovner; Laurel L Northouse; Angela Fagerlin; Carol Garlinghouse; Raymond Y Demers; David R Rovner; May Darwish-Yassine; John T Wei Journal: Urol Oncol Date: 2011-07-20 Impact factor: 3.498
Authors: Katherine S Virgo; Catherine C Lerro; Carrie N Klabunde; Craig Earle; Patricia A Ganz Journal: J Clin Oncol Date: 2013-05-20 Impact factor: 44.544
Authors: Carrie N Klabunde; Paul K J Han; Craig C Earle; Tenbroeck Smith; John Z Ayanian; Richard Lee; Anita Ambs; Julia H Rowland; Arnold L Potosky Journal: Fam Med Date: 2013 Jul-Aug Impact factor: 1.756
Authors: C N Klabunde; D Haggstrom; K L Kahn; S W Gray; B Kim; B Liu; J Eisenstein; N L Keating Journal: Eur J Cancer Care (Engl) Date: 2017-01-10 Impact factor: 2.520
Authors: Mark Lazenby; Elizabeth Ercolano; Marcia Grant; Jimmie C Holland; Paul B Jacobsen; Ruth McCorkle Journal: J Oncol Pract Date: 2015-03-10 Impact factor: 3.840
Authors: Bridgette Thom; Annelies H Boekhout; Stacie Corcoran; Roberto Adsuar; Kevin C Oeffinger; Mary S McCabe Journal: J Oncol Pract Date: 2019-01-07 Impact factor: 3.840
Authors: J L Tucholka; N Jacobson; N M Steffens; J R Schumacher; A J Tevaarwerk; B Anderson; L G Wilke; C C Greenberg; Heather B Neuman Journal: Support Care Cancer Date: 2018-01-13 Impact factor: 3.603